These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Commentary on "Early (<7 Days) Systemic Postnatal Corticosteroids for Prevention of Bronchopulmonary Dysplasia in Preterm Infants". Bamat NA; Soll RF Neonatology; 2023; 120(6):805-811. PubMed ID: 37699378 [No Abstract] [Full Text] [Related]
25. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis. Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547 [TBL] [Abstract][Full Text] [Related]
26. Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016-17 cohort. Douglas E; Hodgson KA; Olsen JE; Manley BJ; Roberts CT; Josev E; Anderson PJ; Doyle LW; Davis PG; Cheong JLY; Acta Paediatr; 2023 Jun; 112(6):1226-1232. PubMed ID: 36719082 [TBL] [Abstract][Full Text] [Related]
27. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants. Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB; JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165 [TBL] [Abstract][Full Text] [Related]
28. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266 [TBL] [Abstract][Full Text] [Related]
29. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants. Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE; JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165 [TBL] [Abstract][Full Text] [Related]
30. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia. Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409 [TBL] [Abstract][Full Text] [Related]
31. Bronchopulmonary dysplasia precursors influence risk of white matter injury and adverse neurodevelopmental outcome in preterm infants. Grelli KN; Keller RL; Rogers EE; Partridge JC; Xu D; Barkovich AJ; Gano D Pediatr Res; 2021 Aug; 90(2):359-365. PubMed ID: 32937647 [TBL] [Abstract][Full Text] [Related]
32. Neurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia. Gallini F; Arena R; Stella G; Frezza S; Maggio L Acta Biomed; 2014 Jun; 85(1):30-4. PubMed ID: 24957344 [TBL] [Abstract][Full Text] [Related]
33. Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Grier DG; Halliday HL Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833 [TBL] [Abstract][Full Text] [Related]
34. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia. Gallini F; Coppola M; De Rose DU; Maggio L; Arena R; Romano V; Cota F; Ricci D; Romeo DM; Mercuri EM; Vento G Early Hum Dev; 2021 Jan; 152():105275. PubMed ID: 33227635 [TBL] [Abstract][Full Text] [Related]
35. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes. Cuna A; Lewis T; Dai H; Nyp M; Truog WE Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393 [TBL] [Abstract][Full Text] [Related]
36. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. Shah SS; Ohlsson A; Halliday HL; Shah VS Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425 [TBL] [Abstract][Full Text] [Related]
37. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906 [TBL] [Abstract][Full Text] [Related]
38. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Doyle LW; Ehrenkranz RA; Halliday HL Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126 [TBL] [Abstract][Full Text] [Related]
39. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. Kelly EN; Shah VS; Levenbach J; Vincer M; DaSilva O; Shah PS; J Matern Fetal Neonatal Med; 2018 Oct; 31(20):2665-2672. PubMed ID: 28714339 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia. Upadhyay K; Vallarino DA; Talati AJ BMC Pediatr; 2020 Sep; 20(1):414. PubMed ID: 32873254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]